Obsessive-compulsive Disorder: The Genetic Links Between Traits and Clinical Diagnosis
Original Article Reference
This SciPod is a summary of the open access paper ‘Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder’, published in the journal Translational Psychiatry. https://doi.org/10.1038/s41398-020-01121-9
About this episode
Although obsessive-compulsive disorder (OCD) is a commonly occurring psychiatric disorder, the underlying genetic basis has until recently, remained poorly defined. Drs Christie Burton, Jennifer Crosbie, and Russell Schachar at The Hospital for Sick Children (SickKids) in Toronto, Canada, and Dr. Paul Arnold at the University of Calgary and The Mathison Centre for Mental Health Research & Education and their extensive network of collaborators conducted a genome-wide association study to address this key gap. These researchers are the first to empirically demonstrate that OCD and obsessive-compulsive traits have a shared genetic risk, and start to pinpoint the genetic basis of this.
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More episodes
Professor Thomas Münzel | Nicotine: The Molecule the Tobacco Industry Doesn’t Want You to Question
For decades, the story of tobacco and the heart seemed settled. Cigarettes were dangerous because they burned, releasing tar, carbon monoxide, and thousands of toxic chemicals that wrecked blood vessels. Remove the fire, the thinking went, and you remove almost all of the danger. That’s the logic behind heat-not-burn devices, e-cigarettes, and now nicotine pouches, each marketed, in turn, as the “safer” next step for people who can’t or won’t quit nicotine altogether.
Prof. Jean-Sébastien Delisle – Dr Mélanie Dieudé | The Medicine Is Ready. Is the Health System?
A medical breakthrough is only truly a breakthrough if it can reach the person who needs it. That simple idea sits at the heart of a rapidly growing challenge in cell therapy, gene therapy and regenerative medicine. These treatments are beginning to change what doctors can offer people with serious cancers, rare genetic conditions and other diseases once considered extraordinarily difficult to treat. Some therapies can reprogram a patient’s own cells to attack cancer. Others aim to repair or replace faulty biological instructions. Their promise can sound futuristic, yet the central problem is increasingly practical: how do we turn remarkable science into care that is affordable, timely and available to everyone who could benefit?
Prof. Yuben Moodley | Signals in the Scars: The Search for New Ways to Predict and Treat Lung Fibrosis
Breathing is so automatic that most of us notice it only when something goes wrong. Yet every breath depends on an extraordinarily delicate structure. Inside the lungs, tiny air sacs provide a vast, thin surface across which oxygen enters the blood. When that tissue is repeatedly injured, the body’s attempt to repair it can become part of the problem. Instead of restoring flexible lung tissue, repair processes may leave behind excessive scar tissue. As this fibrosis accumulates, the lungs become stiffer and less able to perform their essential task.
Prof. John Kopchick | Turning Off Cancer’s Growth Signal: The Unexpected New Life of a Growth Hormone Related Drug
When most of us hear “growth hormone,” we think of childhood, with bones lengthening, bodies developing, and the remarkable biological machinery that turns a small child into an adult. Growth hormone, or GH, deserves that reputation. Produced mainly by the pituitary gland, it helps regulate growth, metabolism, organ development and the production of another important messenger, insulin-like growth factor 1. Yet decades of research have revealed a more complicated story. The same signals that encourage healthy cells to grow and adapt can, in the wrong setting, help cancer cells survive.Because of these unanswered questions, researchers around the world continue searching for new ways to understand gravity. One intriguing contribution comes from Prof. Roberto Sussman and Dr. Sebastián Nájera of the National Autonomous University of Mexico, who have proposed a new gravity theory they denote as “Schouten–Codazzi Gravity”. Their work explores whether gravity might be described by a modified set of mathematical rules that remain closely connected to Einstein’s theory while opening the door to new possibilities.
Increase the impact of your research
• Good science communication helps people make informed decisions and motivates them to take appropriate and affirmative action.
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.
Step 1 Upload your science paper
Step 2 SciPod script written
Step 3 Voice audio recorded
Step 4 SciPod published



